These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17568508)

  • 1. [Treatment of dislipemia in patients with metabolic syndrome or diabetes mellitus].
    Millán J;
    Med Clin (Barc); 2007 May; 128(20):786-94. PubMed ID: 17568508
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome.
    Dickson-Humphries T; Bottenberg B; Kuntz S
    JAAPA; 2013 Jul; 26(7):13-8. PubMed ID: 23923282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing multiple cardiovascular risk factors: state of the science.
    Levine JH
    J Clin Hypertens (Greenwich); 2006 Oct; 8(10 Suppl 3):12-22. PubMed ID: 17028479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
    ; ; Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F
    Cardiol Rev; 2005; 13(6):322-7. PubMed ID: 16708441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in clinical care of cardiovascular diseases complicated with diabetes mellitus].
    Sone H; Yamada N
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):794-801. PubMed ID: 19472542
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines on the management of arterial hypertension and related comorbidities in Latin America.
    Task Force of the Latin American Society of Hypertension
    J Hypertens; 2017 Aug; 35(8):1529-1545. PubMed ID: 28520612
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?
    Hitman GA
    Diabet Med; 2011 Nov; 28(11):1281. PubMed ID: 22004300
    [No Abstract]   [Full Text] [Related]  

  • 9. [The heart of women is not like it used to be, either. Cardiovascular risk factors and their treatment. Interview with Dr. Gábor Simonyi by Anna Radnai].
    Simonyi G
    Orv Hetil; 2013 Mar; 154(10):399-400. PubMed ID: 23461983
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.
    Bril F; Cusi K
    Diabetes Care; 2017 Mar; 40(3):419-430. PubMed ID: 28223446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic diseases and cerebral white matter lesions].
    Yokote K; Sonezaki K; Saito Y
    Nihon Ronen Igakkai Zasshi; 2007 May; 44(3):325-7. PubMed ID: 17575435
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome.
    Twedell D
    J Contin Educ Nurs; 2006; 37(4):150-1. PubMed ID: 16892664
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin tags: a useful clinical sign for insulin resistance?
    Crook M
    Eur J Dermatol; 2012; 22(1):5-6. PubMed ID: 22237167
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between diffuse idiopathic skeletal hyperostosis, abdominal aortic calcification and associated metabolic disorders: Data from the Camargo Cohort.
    Pariente-Rodrigo E; Sgaramella GA; Olmos-Martínez JM; Pini-Valdivieso SF; Landeras-Alvaro R; Hernández-Hernández JL
    Med Clin (Barc); 2017 Sep; 149(5):196-202. PubMed ID: 28283270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemias in chronic kidney disease.
    Szromba C
    Nephrol Nurs J; 2006; 33(5):575-6. PubMed ID: 17044444
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
    Marchitto N; Sindona F; Fabrizio A; Mauti M; Andreozzi S; Dalmaso S; Raimondi G
    Minerva Cardioangiol; 2018 Feb; 66(1):124-125. PubMed ID: 29264910
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic syndrome.
    Dominiczak MH
    Curr Opin Lipidol; 2003 Jun; 14(3):329-32. PubMed ID: 12840663
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihypertensive therapy in the patient with diabetes mellitus or metabolic syndrome].
    Miyashita K; Itoh H
    Nihon Naika Gakkai Zasshi; 2011 Feb; 100(2):376-84. PubMed ID: 21400874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.